Blockchain networks face a quiet but serious problem that grows over time. As transactions pile up, nodes must store more ...

Neuromorphic computers, inspired by the architecture of the human brain, are proving surprisingly adept at solving complex ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Tessellations aren’t just eye-catching patterns—they can be used to crack complex mathematical problems. By repeatedly ...

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...